Advisor Group Holdings, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 10,846 shares of AUPH stock, worth $78,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,846
Previous 11,258
3.66%
Holding current value
$78,958
Previous $56,000
8.93%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AUPH
# of Institutions
191Shares Held
56.2MCall Options Held
499KPut Options Held
637K-
Armistice Capital, LLC New York, NY11.1MShares$81.1 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$67.5 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$28.9 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$21 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$20.2 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.03B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...